Chapter 5 Maternal Fumonisin Exposure as a Risk Factor for Neural Tube Defects

Advances in Food and Nutrition Research

Volumn 56, Issue , 2009, Pages 145-181

  Gelineau van Waes, J ^a   Voss, K A ^b   Stevens, V L ^c   Speer, M C ^d   Riley, R T ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUMONISIN; SPHINGOLIPID; TERATOGENIC AGENT;

ANIMAL; CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID DEFICIENCY; FOOD CONTAMINATION; GENETIC PREDISPOSITION; HUMAN; LEGAL ASPECT; MAIZE; MALE; MATERNAL NUTRITION; METABOLISM; NEURAL TUBE DEFECT; NEWBORN; PREGNANCY; REVIEW; RISK FACTOR; STANDARD;

ANIMALS; FEMALE; FOLIC ACID DEFICIENCY; FOOD CONTAMINATION; FUMONISINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NEURAL TUBE DEFECTS; PREGNANCY; RISK FACTORS; SPHINGOLIPIDS; TERATOGENS; ZEA MAYS;

EID: 64749088908     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1043-4526(08)00605-0     Document Type: Review

References (183)

1. 1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology 131 2-3 (1998) 121-131
2. Barber R.C., Bennett G.D., Greer K.A., and Finnell R.H. Expression patterns of folate binding proteins one and two in the developing mouse embryo. Mol. Genet. Metab. 66 1 (1999) 31-39
3. Ben Othmane K., Rochelle J.M., Ben Hamida M., Slotterbeck B., Rao N., Hentati F., Pericak-Vance M.A., and Vance J.M. Fine localization of the CMT4A locus using a PAC contig and haplotype analysis. Neurogenetics 2 1 (1998) 18-23
4. Betz F.S., Hammond B.G., and Fuchs R.L. Safety and advantages of Bacillus thuringiensis-protected plants to control insect pests. Regul. Toxicol. Pharmacol. 32 2 (2000) 156-173
5. Bhandari N., Enongene E.N., Riley R.T., Meredith F.I., and Sharma R.P. Temporal expression of fumonisin B(1)-induced tumor necrosis factor-alpha and interferon gamma in mice. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 131 2 (2002) 113-122
6. Bischoff A., Finger J., and Michel M.C. Nifedipine inhibits sphinogosine-1-phosphate-induced renovascular contraction in vitro and in vivo. Naunyn. Schmiedebergs Arch. Pharmacol. 364 2 (2001) 179-182
7. Bolger M.C.R.D., Dinovi M., Gaylor D., Gelderblom W.C., Olsen M., Paster N., Riley R.T., Shephard G., and Spijers G.J.A. Fumonisins. Safety evaluation of certain mycotoxin in food International Programme on Chemical Safetty World Health Organization. FAQ FOOD and Nutrition Paper 74 Vol. 47 (2001), WHO - Food Additives Series, Geneva 103-279
8. Bondy G.S., Barker M.G., Lombaert G.A., Armstrong C.L., Fernie S.M., Gurofsky S., Huzel V., Savard M.E., and Curran I.H. A comparison of clinical, histopathological and cell-cycle markers in rats receiving the fungal toxins fumonisin B1 or fumonisin B2 by intraperitoneal injection. Food Chem. Toxicol. 38 10 (2000) 873-886
9. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol. Ther. 115 1 (2007) 84-105
10. Broman K.W., Murray J.C., Sheffield V.C., White R.L., and Weber J.L. Comprehensive human genetic maps: Individual and sex-specific variation in recombination. Am. J. Hum. Genet. 63 3 (1998) 861-869
11. Brown D.A., and London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14 (1998) 111-136
12. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275 23 (2000) 17221-17224
13. Burton K.E., Steele F.M., Jefferies L., Pike O.A., and Dunn M.L. Effect of micronutrient fortification on nutritional and other properties of nixtamal tortillas. Cereal Chem. 85 1 (2008) 70-75
14. Cacic M. Gangliosides of anencephalic and fetal brain - immunostaining on thin-layer chromatograms. Neuroreport 6 2 (1995) 389-393
15. Campbell L.R., Dayton D.H., and Sohal G.S. Neural tube defects: A review of human and animal studies on the etiology of neural tube defects. Teratology 34 2 (1986) 171-187
16. Cárdenas J.D.F., Godinez M.G.A., Méndez N.L.V., Guzmán A.L., Acosta L.M.F., and González-Hernández J. Fortificacion y evaluacion de tortillas de nixtamal. Arch. Latinoam. Nutr. 51 3 (2001) 293-302
17. Castoria R., Lima G., Ferracane R., and Ritieni A. Occurrence of mycotoxin in Farro samples from southern Italy. J. Food Prot. 68 2 (2005) 416-420
18. Chalfant C.E., and Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling. J. Cell Sci. 118 Pt 20 (2005) 4605-4612
19. Chang W.J., Rothberg K.G., Kamen B.A., and Anderson R.G. Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J. Cell Biol. 118 1 (1992) 63-69
20. Chatkupt S., Skurnick J.H., Jaggi M., Mitruka K., Koenigsberger M.R., and Johnson W.G. Study of genetics, epidemiology, and vitamin usage in familial spina bifida in the United States in the 1990s. Neurology 44 1 (1994) 65-70
21. Chatterjee S., Smith E.R., Hanada K., Stevens V.L., and Mayor S. GPI anchoring leads to sphingolipid-dependent retention of endocytosed proteins in the recycling endosomal compartment. EMBO J. 20 7 (2001) 1583-1592
22. Chu F.S., and Li G.Y. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl. Environ. Microbiol. 60 3 (1994) 847-852
23. Cifuentes G. Perfil epidemiologico de law anomalias del tubo neural en Guatemala, durante el ano 2000. Graduation Thesis of the School of Medicine of Universidad San Carlos de Guatemala (2002)
24. Collins T.F., Shackelford M.E., Sprando R.L., Black T.N., Laborde J.G., Hansen D.K., Eppley R.M., Trucksess M.W., Howard P.C., Bryant M.A., Ruggles D.I., Olejnik N., et al. Effects of fumonisin B1 in pregnant rats. Food Chem. Toxicol. 36 5 (1998) 397-408
25. Commission of European Communities. Commission Regulation (EC) No. 856/2005 of 6 June 2005 amending Regulation (EC) No 466/2001 as regards Fusarium toxins: (2005) 3-8
26. Constable P.D., Smith G.W., Rottinghaus G.E., and Haschek W.M. Ingestion of fumonisin B1-containing culture material decreases cardiac contractility and mechanical efficiency in swine. Toxicol. Appl. Pharmacol. 162 3 (2000) 151-160
27. Constable P.D., Smith G.W., Rottinghaus G.E., Tumbleson M.E., and Haschek W.M. Fumonisin-induced blockade of ceramide synthase in sphingolipid biosynthetic pathway alters aortic input impedance spectrum of pigs. Am. J. Physiol. Heart Circ. Physiol. 284 6 (2003) H2034-2044
28. 1. AOAC International Midwest Section Final Program (2005) 63-64
29. Copp A.J., Greene N.D., and Murdoch J.N. The genetic basis of mammalian neurulation. Nat. Rev. Genet. 4 10 (2003) 784-793
30. Corona G., Giannini F., Fabris M., Toffoli G., and Boiocchi M. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. Int. J. Cancer 75 1 (1998) 125-133
31. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23 (2005) 127-159
32. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327 26 (1992) 1832-1835
33. da Costa M., Sequeira J.M., Rothenberg S.P., and Weedon J. Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Res. A Clin. Mol. Teratol. 67 10 (2003) 837-847
34. da Silva J.B., Pozzi C.R., Mallozzi M.A., Ortega E.M., and Correa B. Mycoflora and occurrence of aflatoxin B(1) and fumonisin B(1) during storage of Brazilian sorghum. J. Agric. Food Chem. 48 9 (2000) 4352-4356
35. Dev K.K., Mullershausen F., Mattes H., Kuhn R.R., Bilbe G., Hoyer D., and Mir A. Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis. Pharmacol. Ther. 117 1 (2008) 77-93
36. Dombrink-Kurtzman M.A., Dvorak T.J., Barron M.E., and Rooney L.W. Effect of nixtamalization (Alkaline cooking) on fumonisin-contaminated corn for production of masa and tortillas. J. Agric. Food. Chem. 48 11 (2000) 5781-5786
37. Dragan Y.P., Bidlack W.R., Cohen S.M., Goldsworthy T.L., Hard G.C., Howard P.C., Riley R.T., and Voss K.A. Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: Fumonisin B(1) as an example. Toxicol. Sci. 61 1 (2001) 6-17
38. Duvick J. Prospects for reducing fumonisin contamination of maize through genetic modification. Environ. Health Perspect. 109 Suppl 2 (2001) 337-342
39. Elortza F., Nuhse T.S., Foster L.J., Stensballe A., Peck S.C., and Jensen O.N. Proteomic analysis of glycosylphosphatidylinositol-anchored membrane proteins. Mol. Cell Proteomics 2 12 (2003) 1261-1270
40. Enongene E.N., Sharma R.P., Bhandari N., Miller J.D., Meredith F.I., Voss K.A., and Riley R.T. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. Toxicol. Sci. 67 (2002) 173-181
41. Floss J.L., Casteel S.W., Johnson G.C., Rottinghaus G.E., and Krause G.F. Development toxicity of fumonisin in Syrian hamsters. Mycopathologia 128 1 (1994) 33-38
42. Flynn T.J., Stack M.E., Troy A.L., and Chirtel S.J. Assessment of the embryotoxic potential of the total hydrolysis product of fumonisin B1 using cultured organogenesis-staged rat embryos. Food Chem. Toxicol. 35 12 (1997) 1135-1141
43. Foster L.J., De Hoog C.L., and Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. USA 100 10 (2003) 5813-5818
44. Futerman A.H., and Hannun Y.A. The complex life of simple sphingolipids. EMBO Rep. 5 8 (2004) 777-782
45. Gelderblom W.C., Jaskiewicz K., Marasas W.F., Thiel P.G., Horak R.M., Vleggaar R., and Kriek N.P. Fumonisins - Novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 54 7 (1988) 1806-1811
46. Gelderblom W.C., Kriek N.P., Marasas W.F., and Thiel P.G. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 12 7 (1991) 1247-1251
47. Gelderblom W.C., Seier J.V., Snijman P.W., van Schalkwyk D.J., Shephard G.S., and Marasas W.F. Toxicity of culture material of Fusarium verticillioides strain MRC 826 to nonhuman primates. Environ. Health Perspect. 109 Suppl 2 (2001) 267-276
48. Gelineau-van Waes J., Starr L., Maddox J., Aleman F., Voss K.A., Wilberding J., and Riley R.T. Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model. Birth Defects Res. A Clin. Mol. Teratol. 73 7 (2005) 487-497
49. Goldman I.D. The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann. NY Acad. Sci. 186 (1971) 400-422
50. Gon Y., Wood M.R., Kiosses W.B., Jo E., Sanna M.G., Chun J., and Rosen H. S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc. Natl. Acad. Sci. USA 102 26 (2005) 9270-9275
51. Gong Y.Y., Sanchez L.T., Carrillo L.L., Peng J.H., Sutcliffe A.E., White K.L., Humpf H.U., Turner P.C., and Wild C.P. Association between tortilla consumption and human urinary fumonisin B1 levels in a Mexican population. Cancer Epidemiol. Biomarkers Prev. 17 3 (2008) 688-694
52. Gopee N.V., and Sharma R.P. The mycotoxin fumonisin B1 transiently activates nuclear factor-kappaB, tumor necrosis factor alpha and caspase 3 via protein kinase C alpha-dependent pathway in porcine renal epithelial cells. Cell Biol. Toxicol. 20 4 (2004) 197-212
53. Gross S.M., Reddy R.V., Rottinghaus G.E., Johnson G., and Reddy C.S. Developmental effects of fumonisin B1-containing Fusarium moniliforme culture extract in CD1 mice. Mycopathologia 128 2 (1994) 111-118
54. Gudbjartsson D.F., Jonasson K., Frigge M.L., and Kong A. Allegro, a new computer program for multipoint linkage analysis. Nat. Genet. 25 1 (2000) 12-13
55. Hansen D.K., Streck R.D., and Antony A.C. Antisense modulation of the coding or regulatory sequence of the folate receptor (folate binding protein-1) in mouse embryos leads to neural tube defects. Birth Defects Res. Part A Clin. Mol. Teratol. 67 7 (2003) 475-487
56. Hard G.C., Howard P.C., Kovatch R.M., and Bucci T.J. Rat kidney pathology induced by chronic exposure to fumonisin B1 includes rare variants of renal tubule tumor. Toxicol. Pathol. 29 3 (2001) 379-386
57. Haschek W.M., Gumprecht L.A., Smith G., Tumbleson M.E., and Constable P.D. Fumonisin toxicosis in swine: An overview of porcine pulmonary edema and current perspectives. Environ. Health Perspect. 109 Suppl 2 (2001) 251-257
58. Hendricks K. Fumonisins and neural tube defects in South Texas. Epidemiology 10 2 (1999) 198-200
59. Hoessli D.C., Ilangumaran S., Soltermann A., Robinson P.J., Borisch B., and Nasir Ud D. Signaling through sphingolipid microdomains of the plasma membrane: The concept of signaling platform. Glycoconj J. 17 3-4 (2000) 191-197
60. Howard P.C., Warbritton A., Voss K.A., Lorentzen R.J., Thurman J.D., Kovach R.M., and Bucci T.J. Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat. Environ. Health Perspect 109 Suppl 2 (2001) 309-314
61. Howard P.C., Eppley R.M., Stack M.E., Warbritton A., Voss K.A., Lorentzen R.J., Kovach R.M., and Bucci T.J. Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect 109 Suppl 2 (2001) 277-282
62. Howard P.C., Couch L.H., Patton R.E., Eppley R.M., Doerge D.R., Churchwell M.I., Marques M.M., and Okerberg C.V. Comparison of the toxicity of several fumonisin derivatives in a 28-day feeding study with female B6C3F(1) mice. Toxicol. Appl. Pharmacol. 185 3 (2002) 153-165
63. Hsiao S.H., Constable P.D., Smith G.W., and Haschek W.M. Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings. Toxicol. Sci. 86 1 (2005) 194-199
64. Humpf H.U., and Voss K.A. Effects of thermal food processing on the chemical structure and toxicity of fumonisin mycotoxins. Mol. Nutr. Food Res. 48 4 (2004) 255-269
65. IARC. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans (2002), IARC Press, Lyon
66. Ilangumaran S., Arni S., van Echten-Deckert G., Borisch B., and Hoessli D.C. Microdomain-dependent regulation of Lck and Fyn protein-tyrosine kinases in T lymphocyte plasma membranes. Mol. Biol. Cell 10 4 (1999) 891-905
67. Im D.S., Clemens J., Macdonald T.L., and Lynch K.R. Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): Structure-activity relationship of sphingosine1-phosphate receptors. Biochemistry 40 46 (2001) 14053-14060
68. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2002), IARC Press, Lyon 301-366
69. Juriloff D.M., and Harris M.J. Mouse models for neural tube closure defects. Hum. Mol. Genet. 9 6 (2000) 993-1000
70. Kamen B.A., and Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc. Natl. Acad. Sci. 83 16 (1986) 5983-5987
71. Khoury M.J., Beaty T.H., and Liang K.Y. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?. Am. J. Epidemiol. 127 3 (1988) 674-683
72. Kim E.K., Scott P.M., and Lau B.P. Hidden fumonisin in corn flakes. Food Addit. Contam. 20 2 (2003) 161-169
73. Kim M.S., Lee D.Y., Wang T., and Schroeder J.J. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway. Toxicol. Appl. Pharmacol. 176 2 (2001) 118-126
74. Kintz P. Value of hair analysis in postmortem toxicology. Forensic Sci. Int. 142 2-3 (2004) 127-134
75. Kong A., and Cox N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61 5 (1997) 1179-1188
76. Kono M., Mi Y., Liu Y., Sasaki T., Allende M.L., Wu Y.P., Yamashita T., and Proia R.L. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem. 279 28 (2004) 29367-29373
77. Kouadio J.H., Mobio T.A., Baudrimont I., Moukha S., Dano S.D., and Creppy E.E. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology 213 1-2 (2005) 56-65
78. Krapels I.P., Rooij I.A., Wevers R.A., Zielhuis G.A., Spauwen P.H., Brussel W., and Steegers-Theunissen R.P. Myo-inositol, glucose and zinc status as risk factors for non-syndromic cleft lip with or without cleft palate in offspring: A case-control study. BJOG 111 7 (2004) 661-668
79. Kritzinger Q., Aveling T.A., Marasas W.F., Rheeder J.P., van der Westhuizen L., and Shephard G.S. Mycoflora and fumonisin mycotoxins associated with cowpea [Vigna unguiculata (L.) Walp] seeds. J. Agric. Food Chem. 51 8 (2003) 2188-2192
80. Kromberg J.G., and Jenkins T. Common birth defects in South African Blacks. S. Afr. Med. J. 62 17 (1982) 599-602
81. Kruglyak L., Daly M.J., Reeve-Daly M.P., and Lander E.S. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am. J. Hum. Genet. 58 6 (1996) 1347-1363
82. Leck I. Spina bifida and anencephaly: Fewer patients, more problems. Br. Med. J. (Clin. Res. Ed.) 286 6379 (1983) 1679-1680
83. Lemke S.L., Ottinger S.E., Ake C.L., Mayura K., and Phillips T.D. Deamination of fumonisin B(1) and biological assessment of reaction product toxicity. Chem. Res. Toxicol. 14 1 (2001) 11-15
84. Lemmer E.R., Gelderblom W.C., Shephard E.G., Abel S., Seymour B.L., Cruse J.P., Kirsch R.E., Marasas W.F., and Hall P.M. The effects of dietary iron overload on fumonisin B1-induced cancer promotion in the rat liver. Cancer Lett. 146 2 (1999) 207-215
85. Lin S., Naim H.Y., Rodriguez A.C., and Roth M.G. Mutations in the middle of the transmembrane domain reverse the polarity of transport of the influenza virus hemagglutinin in MDCK epithelial cells. J. Cell Biol. 142 1 (1998) 51-57
86. Lu Y., Clifford L., Hauck C.C., Hendrich S., Osweiler G., and Murphy P.A. Characterization of fumonisin B(1)-glucose reaction kinetics and products. J. Agric. Food Chem. 50 16 (2002) 4726-4733
87. Marasas W.F. Fumonisins: History, world-wide occurrence and impact. Adv. Exp. Med. Biol. 392 (1996) 1-17
88. Marasas W.F. Discovery and occurrence of the fumonisins: A historical perspective. Environ. Health Perspect. 109 Suppl 2 (2001) 239-243
89. Marasas W.F., Riley R.T., Hendricks K.A., Stevens V.L., Sadler T.W., Gelineau-van Waes J., Missmer S.A., Cabrera J., Torres O., Gelderblom W.C., Allegood J., Martinez C., et al. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: A potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutr. 134 4 (2004) 711-716
90. Martin E.R., Lai E.H., Gilbert J.R., Rogala A.R., Afshari A.J., Riley J., Finch K.L., Stevens J.F., Livak K.J., Slotterbeck B.D., Slifer S.H., Warren L.L., et al. SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 67 2 (2000) 383-394
91. Martinez de Villarreal L., Perez J.Z., Vazquez P.A., Herrera R.H., del Campos M.R., Lopez R.A., Ramirez J.L., Sanchez J.M., Villarreal J.J., Garza M.T., Limon A., Lopez A.G., et al. Decline of neural tube defects cases after a folic acid campaign in Nuevo Leon, Mexico. Teratology 66 5 (2002) 249-256
92. Matise T.C., Sachidanandam R., Clark A.G., Kruglyak L., Wijsman E., Kakol J., Buyske S., Chui B., Cohen P., de Toma C., Ehm M., Glanowski S., et al. A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am. J. Hum. Genet. 73 2 (2003) 271-284
93. Mayor S., Sabharanjak S., and Maxfield F.R. Cholesterol-dependent retention of GPI-anchored proteins in endosomes. EMBO J. 17 16 (1998) 4626-4638
94. Melnick M., and Marazita M.L. Neural tube defects, methylenetetrahydrofolate reductase mutation, and north/south dietary differences in China. J. Craniofac Genet. Dev. Biol. 18 4 (1998) 233-235
95. Meredith F.I., Torres O.R., Saenz de Tejada S., Riley R.T., and Merrill Jr. A.H. Fumonisin B1 and hydrolyzed fumonisin B1 (AP1) in tortillas and nixtamalized corn (Zea mays L.) from two different geographic locations in Guatemala. J. Food Prot. 62 10 (1999) 1218-1222
96. Merrill Jr. A.H., Sullards M.C., Wang E., Voss K.A., and Riley R.T. Sphingolipid metabolism: Roles in signal transduction and disruption by fumonisins. Environ. Health Perspect 109 Suppl 2 (2001) 283-289
97. Miller J. Occurrence of Fusarium and fumonisins on food grains and in foods. Environ. Health Perspect 109 Suppl 2 (2001) 321-324
98. Milunsky A., Jick H., Jick S.S., Bruell C.L., MacLaughlin D.S., Rothman K.J., and Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262 20 (1989) 2847-2852
99. Miotti S., Bagnoli M., Ottone F., Tomassetti A., Colnaghi M.I., and Canevari S. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines. J. Cell Biochem. 65 4 (1997) 479-491
100. Miotti S., Bagnoli M., Tomassetti A., Colnaghi M.I., and Canevari S. Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1. J. Cell Sci. 113 Pt 2 (2000) 349-357
101. Missmer S.A., Suarez L., Felkner M., Wang E., Merrill Jr. A.H., Rothman K.J., and Hendricks K.A. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ. Health Perspect 114 2 (2006) 237-241
102. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., and Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell Biol. 25 24 (2005) 11113-11121
103. Mizugishi K., Li C., Olivera A., Bielawski J., Bielawski A., Deng C.X., and Proia R.L. Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. J. Clin. Invest. 117 10 (2007) 2993-3006
104. Moore C.A., Li S., Li Z., Hong S.X., Gu H.Q., Berry R.J., Mulinare J., and Erickson J.D. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am. J. Med. Genet. 73 2 (1997) 113-118
105. Morrison K., Papapetrou C., Hol F.A., Mariman E.C., Lynch S.A., Burn J., and Edwards Y.H. Susceptibility to spina bifida; an association study of five candidate genes. Ann. Hum. Genet. 62 Pt 5 (1998) 379-396
106. MRC. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338 8760 (1991) 131-137
107. Murray J.C., Daack-Hirsch S., Buetow K.H., Munger R., Espina L., Paglinawan N., Villanueva E., Rary J., Magee K., and Magee W. Clinical and epidemiologic studies of cleft lip and palate in the Philippines. Cleft Palate Craniofac J. 34 1 (1997) 7-10
108. Nakano K.K. Anencephaly: A review. Dev. Med. Child Neurol. 15 3 (1973) 383-400
109. Ncayiyana D.J. Neural tube defects among rural blacks in a Transkei district. A preliminary report and analysis. S Afr. Med. J. 69 10 (1986) 618-620
110. Norred W.P., Plattner R.D., Meredith F.I., and Riley R.T. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: Specificity of the response and structure-activity relationships. Toxicol. Appl. Pharmacol. 147 (1997) 63-70
111. 1 (FA1) and the impact on inhibition of ceramide synthase in rat liver slices. Food Chem. Toxicol. 39 (2001) 1071-1078
112. O'Connell J.R., and Weeks D.E. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance. Nat. Genet. 11 4 (1995) 402-408
113. Page S.T., Owen W.C., Price K., and Elwood P.C. Expression of the human placental folate receptor transcript is regulated in human tissues. Organization and full nucleotide sequence of the gene. J. Mol. Biol. 229 4 (1993) 1175-1183
114. Palencia E., Torres O., Hagler W., Meredith F.I., Williams L.D., and Riley R.T. Total fumonisins are reduced in tortillas using the traditional nixtamalization method of Mayan communities. J. Nutr. 133 (2003) 3200-3203
115. Park J.W., Scott P.M., Lau B.P., and Lewis D.A. Analysis of heat-processed corn foods for fumonisins and bound fumonisins. Food Addit. Contam. 21 12 (2004) 1168-1178
116. Pelagalli A., Belisario M.A., Squillacioti C., Della Morte R., d'Angelo D., Tafuri S., Lucisano A., and Staiano N. The mycotoxin fumonisin B1 inhibits integrin-mediated cell-matrix adhesion. Biochimie 81 10 (1999) 1003-1008
117. Penner J.D., Casteel S.W., Pittman Jr. L., Rottinghaus G.E., and Wyatt R.D. Developmental toxicity of purified fumonisin B1 in pregnant Syrian hamsters. J. Appl. Toxicol. 18 3 (1998) 197-203
118. Piedrahita J.A., Oetama B., Bennett G.D., van Waes J., Kamen B.A., Richardson J., Lacey S.W., Anderson R.G., and Finnell R.H. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 23 (1999) 228-232
119. Piva A., Casadei G., Pagliuca G., Cabassi E., Galvano F., Solfrizzo M., Riley R.T., and Diaz D.E. Activated carbon does not prevent the toxicity of culture material containing fumonisin B1 when fed to weanling piglets. J. Anim. Sci. 83 8 (2005) 1939-1947
120. Powell D.C., Bursian S.J., Bush C.R., Render J.A., Rottinghaus G.E., and Aulerich R.J. Effects of dietary exposure to fumonisins from Fusarium moniliforme culture material (M-1325) on the reproductive performance of female mink. Arch. Environ. Contam. Toxicol. 31 2 (1996) 286-292
121. Prakash K., Pirozzi G., Elashoff M., Munger W., Waga I., Dhir R., Kakehi Y., and Getzenberg R.H. Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays. Proc. Natl. Acad. Sci. 99 11 (2002) 7598-7603
122. Ramasamy S., Wang E., Hennig B., and Merrill Jr. A.H. Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture. Toxicol. Appl. Pharmacol. 133 2 (1995) 343-348
123. Rampersaud E., Bassuk A.G., Enterline D.S., George T.M., Siegel D.G., Melvin E.C., Aben J., Allen J., Aylsworth A., Brei T., Bodurtha J., Buran C., et al. Whole genome-wide linkage screen for neural tube defects reveals regions of interest on chromosomes 7 and 10. J. Med. Genet. 42 12 (2005) 940-946
124. Razin A., and Kantor B. DNA methylation in epigenetic control of gene expression. Prog. Mol. Subcell Biol. 38 (2005) 151-167
125. Reddy R.V., Johnson G., Rottinghaus G.E., Casteel S.W., and Reddy C.S. Developmental effects of fumonisin B1 in mice. Mycopathologia 134 3 (1996) 161-166
126. Reeder J.P., Marasas W.F., and Vismer H.F. Production of fumonisin analogs by Fusarium species. Appl. Environ. Microbiol. 68 5 (2002) 2101-2105
127. Rietveld A., and Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta 1376 3 (1998) 467-479
128. Riley R.T., and Voss K.A. Differential sensitivity of rat kidney and liver to fumonisin toxicity: Organ-specific differences in toxin accumulation and sphingoid base metabolism. Toxicol Sci. 92 1 (2006) 335-345
129. Riley R.T., An N.H., Showker J.L., Yoo H.S., Norred W.P., Chamberlain W.J., Wang E., Merrill Jr. A.H., Motelin G., and Beasley V.R. Alteration of tissue and serum sphinganine to sphingosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol. Appl. Pharmacol. 118 1 (1993) 105-112
130. Riley R.T., Wang E., Schroeder J.J., Smith E.R., Plattner R.D., Abbas H., Yoo H.S., and Merrill Jr. A.H. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins 4 1 (1996) 3-15
131. Riley R.T., Voss K.A., Norred W.P., Bacon C.W., Meredith F.I., and Sharma R.P. Serine palmitoyltransferase inhibition reverses antiproliferative effects of ceramide synthase inhibition in cultured renal cells and suppresses free sphingoid base accumulation in kidney of BALBc mice. Environ. Toxicol. Pharmacol. 7 (1999) 109-118
132. Riley R.T., Enongene E., Voss K.A., Norred W.P., Meredith F.I., Sharma R.P., Spitsbergen J., Williams D.E., Carlson D.B., and Merrill Jr. A.H. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect 109 Suppl 2 (2001) 301-308
133. Riley R.T., Voss K.A., Speer M., Stevens V.L., and Gelineau-van Waes J. Fumonisin inhibition of ceramide synthase: A possible risk factor for human neural tube defects. In: Hirabayashi Y., Merrill Jr. A.H., and Igarashi Y. (Eds). Sphingolipid Biology (2006), Springer, Toyko 345-362
134. Rosenquist T.H., and Finnell R.H. Genes, folate and homocysteine in embryonic development. Proc. Nutr. Soc. 60 1 (2001) 53-61
135. Rothenberg S.P., Da Costa M.P., Sequeira J.M., Cracco J., Roberts J.L., Weedon J., and Quadros E.V. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. Obstet. Gynecol. Surv. 59 6 (2004) 410-411
136. Sabbadini R.A., Betto R., Teresi A., Fachechi-Cassano G., and Salviati G. The effects of sphingosine on sarcoplasmic reticulum membrane calcium release. J. Biol. Chem. 267 22 (1992) 15475-15484
137. Sadler T.W., Merrill Jr. A.H., Stevens V.L., Sullards M.C., Wang E., and Wang P. Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology 66 4 (2002) 169-176
138. Sahu S.C., Eppley R.M., Page S.W., Gray G.C., Barton C.N., and O'Donnell M.W. Peroxidation of membrane lipids and oxidative DNA damage by fumonisin B1 in isolated rat liver nuclei. Cancer Lett. 125 1-2 (1998) 117-121
139. Saitsu H., Ishibashi M., Nakano H., and Shiota K. Spatial and temporal expression of folate-binding protein 1 (Folbp1) is closely associated with anterior neural tube closure in mice. Dev. Dyn. 226 1 (2003) 112-117
140. Sanchez T., Skoura A., Wu M.T., Casserly B., Harrington E.O., and Hla T. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler. Thromb. Vasc. Biol. 27 6 (2007) 1312-1318
141. Sanna M.G., Liao J., Jo E., Alfonso C., Ahn M.Y., Peterson M.S., Webb B., Lefebvre S., Chun J., Gray N., and Rosen H. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279 14 (2004) 13839-13848
142. Scriver C.R. Vitamins: An evolutionary perspective. J. Inherit. Metab. Dis. 8 Suppl 1 (1985) 2-7
143. Seefelder W., Humpf H.U., Schwerdt G., Freudinger R., and Gekle M. Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites. Toxicol. Appl. Pharmacol. 192 2 (2003) 146-153
144. Sewram V., Mshicileli N., Shephard G.S., and Marasas W.F. Fumonisin mycotoxins in human hair. Biomarkers 8 2 (2003) 110-118
145. Shannon K.M., and Fenichel G.M. Pimozide treatment of Sydenham's chorea. Neurology 40 1 (1990) 186
146. Sharma R.P., He Q., Meredith F.I., Riley R.T., and Voss K.A. Paradoxical role of tumor necrosis factor alpha in fumonisin-induced hepatotoxicity in mice. Toxicology 180 3 (2002) 221-232
147. Sharma R.P., He Q., Johnson V.J., and Voss K.A. Increased expression of CD95-ligand and other apoptotic signaling factors by fumonisin B1, a hepatotoxic mycotoxin, in livers of mice lacking tumor necrosis factor alpha. Cytokine 24 5 (2003) 226-236
148. Shaw G.M., Schaffer D., Velie E.M., Morland K., and Harris J.A. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6 3 (1995) 219-226
149. Shephard G.S., Thiel P.G., Stockenstrom S., and Sydenham E.W. Worldwide survey of fumonisin contamination of corn and corn-based products. J. AOAC Int. 79 3 (1996) 671-687
150. Shephard G.S., Marasas W.F., Yazdanpanah H., Rahimian H., Safavi N., Zarghi A., Shafaati A., and Rasekh H.R. Fumonisin B(1) in maize harvested in Iran during 1999. Food Addit. Contam. 19 7 (2002) 676-679
151. Shephard G.S., van der Westhuizen L., and Sewram V. Biomarkers of exposure to fumonisin mycotoxins: A review. Food Addit. Contam. 24 10 (2007) 1196-1201
152. Silani V., Bonifati C., Buscaglia M., Sampietro A., Ghezzi C., and Scarlato G. Ganglioside GM1 expression during human spinal cord and neural crest development. Neuroreport 4 6 (1993) 767-770
153. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 6633 (1997) 569-572
154. Singleton P.A., Dudek S.M., Chiang E.T., and Garcia J.G. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. 19 12 (2005) 1646-1656
155. Smith G.W., Constable P.D., Foreman J.H., Eppley R.M., Waggoner A.L., Tumbleson M., and Haschek W.M. Cardiovascular changes associated with intravenous administration of fumonisin B1 in horses. Am. J. Vet. Res. 63 4 (2002) 538-545
156. Spiegel S., and Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277 29 (2002) 25851-25854
157. Spiegel S., and Milstien S. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4 5 (2003) 397-407
158. Spiegelstein O., Mitchell L.E., Merriweather M.Y., Wicker N.J., Zhang Q., Lammer E.J., and Finnell R.H. Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev. Dyn. 231 1 (2004) 221-231
159. Stamm D.S., Rampersaud E., Slifer S.H., Mehltretter L., Siegel D.G., Xie J., Hu-Lince D., Craig D.W., Stephan D.A., George T.M., Gilbert J.R., and Speer M.C. High-density single nucleotide polymorphism screen in a large multiplex neural tube defect family refines linkage to loci at 7p21.1-pter and 2q33.1-q35. Birth Defects Res. A Clin. Mol. Teratol. 76 6 (2006) 499-505
160. Stevens V.L., and Tang J. Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J. Biol. Chem. 272 29 (1997) 18020-18025
161. Stunff H.L., Milstien S., and Spiegel S. Generation and metabolism of bioactive sphingosine-1-phosphate. J. Cell Biochem. 92 5 (2004) 882-899
162. Suarez L., Hendricks K.A., Cooper S.P., Sweeney A.M., Hardy R.J., and Larsen R.D. Neural tube defects among Mexican Americans living on the US-Mexico border: Effects of folic acid and dietary folate. Am. J. Epidemiol. 152 11 (2000) 1017-10123
163. 1 hepatotoxicity in mice via modulation of sphingosine kinase. Toxicology 229 (2007) 42-53
164. Taha T.A., Hannun Y.A., and Obeid L.M. Sphingosine kinase: Biochemical and cellular regulation and role in disease. J. Biochem. Mol. Biol. 39 2 (2006) 113-131
165. Takabe K., Paugh S.W., Milstien S., and Speigel S. Inside-out" signaling of sphingosine-1-phosphate: Therapeutic targets. Pharmacol. Rev. 60 2 (2008) 181-195
166. Tardieu D., Tran S.T., Auvergne A., Babile R., Benard G., Bailly J.D., and Guerre P. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks. Chem. Biol. Interact 160 1 (2006) 51-60
167. Torres O.A., Palencia E., Lopez de Pratdesaba L., Grajeda R., Fuentes M., Speer M.C., Merrill Jr. A.H., O'Donnell K., Bacon C.W., Glenn A.E., and Riley R.T. Estimated fumonisin exposure in Guatemala is greatest in consumers of lowland maize. J. Nutr. 137 12 (2007) 2723-2729
168. Voss K.A., Plattner R.D., Riley R.T., Meredith F.I., and Norred W.P. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: Fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Mycopathologia 141 1 (1998) 45-58
169. Voss K.A., Riley R.T., Norred W.P., Bacon C.W., Meredith F.I., Howard P.C., Plattner R.D., Collins T.F., Hansen D.K., and Porter J.K. An overview of rodent toxicities: Liver and kidney effects of fumonisins and Fusarium moniliforme. Environ. Health Perspect 109 Suppl 2 (2001) 259-266
170. Voss K.A., Riley R.T., and Gelineau-van Waes J. Trends in fumonisin research: Recent studies on the developmental effects of fumonisins and Fusarium verticillioides. Mycotoxins 55 2 (2006) 91-100
171. Wang E., Norred W.P., Bacon C.W., Riley R.T., and Merrill Jr. A.H. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266 22 (1991) 14486-14490
172. Wang E., Ross P.F., Wilson T.M., Riley R.T., and Merrill Jr. A.H. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr. 122 8 (1992) 1706-17016
173. Wang E., Riley R.T., Meredith F.I., and Merrill Jr. A.H. Fumonisin B1 consumption by rats causes reversible dose-dependent increases in urinary sphinganine and sphingosine. J. Nutr. 129 (1999) 214-220
174. Watanabe R., Funato K., Venkataraman K., Futerman A.H., and Riezman H. Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast. J. Biol. Chem. 277 51 (2002) 49538-49544
175. Watterson K., Sankala H., Milstien S., and Spiegel S. Pleiotropic actions of sphingosine-1-phosphate. Prog. Lipid Res. 42 4 (2003) 344-357
176. Weis B.K., Balshaw D., Barr J.R., Brown D., Ellisman M., Lioy P., Omenn G., Potter J.D., Smith M.T., Sohn L., Suk W.A., Sumner S., et al. Personalized exposure assessment: Promising approaches for human environmental health research. Environ. Health Perspect 113 7 (2005) 840-848
177. Werler M.M., Shapiro S., and Mitchell A.A. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269 10 (1993) 1257-1261
178. WHO. Environmental Health Criteria 219: Fumonisin B1. United Nations Environmental Programme, the International Labour Organization and the World Health Organization International Programme on Chemical Safety Vol. 153 (2000), Geneva, Switzerland
179. Xiao K.Z., Zhang Z.Y., Su Y.M., Liu F.Q., Yan Z.Z., Jiang Z.Q., Zhou S.F., He W.G., Wang B.Y., and Jiang H.P. Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regions of China: Chinese Birth Defects Monitoring Program. Int. J. Epidemiol. 19 4 (1990) 978-982
180. Yazdanpanah H., Shephard G.S., Marasas W.F., van der Westhuizen L., Rahimian H., Safavi S.N., Eskandari P., and Ghiasian S.A. Human dietary exposure to fumonisin B1 from Iranian maize harvested during 1998-2000. Mycopathologia 161 6 (2006) 395-401
181. Yoshizawa T., Yamashita A., and Luo Y. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl. Environ. Microbiol. 60 5 (1994) 1626-1629
182. Yu C.H., Lee Y.M., Yun Y.P., and Yoo H.S. Differential effects of fumonisin B1 on cell death in cultured cells: The significance of the elevated sphinganine. Arch. Pharm. Res. 24 2 (2001) 136-143
183. Zhou J., and Saba J.D. Identification of the first mammalian sphinogosine phosphate lyase gene and its functional expression in yeast. Biochem. Biophys. Res. Commun. 242 3 (1998) 502-507